Skip navigation links
About the Firm
Practice Areas
Our Professionals
Publications
News & Resources
Careers
 
Roylance, Abrams, Berdo
 & Goodman, L.L.P.

1300 19th Street, NW
Suite 600
Washington D.C. 20036
P | 202.659.9076
F | 202.659.9344

SubPage Header Pic

 Drew  Hissong 

Drew Hissong, Of Counsel to the firm, specializes in the preparation and prosecution of biotechnology and pharmaceutical patent applications. He has significant experience in client counseling and in the preparation of freedom to operate, patentability, validity and non-infringement opinions. In addition to serving domestic and international companies, Dr. Hissong’s clients include public and private universities.

Dr. Hissong’s areas of technical expertise include polynucleotides and polypeptides, modulators of apoptosis, mechanisms of signal transduction, cytotoxic agents, molecular tools such as vectors and promoters, assay systems, anti-sense RNA, stems cells, hybridomas and antibodies, and bacterial cell lines. He also has extensive experience in writing and prosecuting patent applications in the fields of antimicrobials, bacteriophage, pharmaceuticals, food products, and inorganic and organic chemistry.

Prior to joining the firm, Dr. Hissong spent 10 years with two other law firms focusing on intellectual property. While in law school, he served as a law clerk and summer associate. Before his law career and while working on his doctorate, Dr. Hissong served as a research assistant at the University of North Carolina at Chapel Hill (UNC), focusing on molecular biology with an emphasis on growth factor maturation and processing. He also taught microbiology to undergraduate students while at UNC.

Education


   Case Western Reserve University School of Law, J.D., 1999

        Executive Editor, Health Matrix: The Journal of Law-Medicine

University of North Carolina at Chapel Hill, Ph.D., Microbiology & Immunology, 1998

University of Illinois at Urbana-Champaign, M.S., Entomology, 1991

Kent State University, B.S., Biology, 1989

Professional Affiliations


   Member, District of Columbia Bar Association

Member, Virginia Bar Association

Member, American Intellectual Property Law Association

Bar & Court Admissions


District of Columbia

Ohio

Virginia

U.S. Court of Appeals for the Federal Circuit

U.S. Patent and Trademark Office

Publications

Co-author, “EST Patents After Fisher:  Decision  Leaves Door Open for Proving Their Utility,” The Patent Lawyer, 2(3):18-19, 2005

Co-author, “The Carboxy-Terminal Valine Residues of ProTGFa are Required for its Efficient Maturation and Intracellular Routing,” Molecular Biology of the Cell, 8:1619-1631, 1997

Co-author, “Transcriptional and Post-Transcriptional Induction of the TGFa Gene in Transformed Rat Liver Epithelial Cells,” Oncogene, 12:1991-2002, 1996

Co-author, “Transforming Growth Factor a: Expression, Regulation, and Biological Activities,” Pharmacological Reviews, 47:51-58, 1995

 Seminars

“Claims Drafting, Boot Camp for New Associates,” Instructor, American Law Intellectual Property Association, August 2007 & 2009

“From the Laboratory to the Court Room:  Careers for Scientists in Patent Law,” Speaker, University of North Carolina-Chapel Hill, April 2005

“Utility Guidelines, Homology Claims and Anti-Sense Molecule Claims,” Speaker, Korean Intellectual Property Office, Republic of Korea, February 2004

“Changes to the Hatch-Waxman Act as Part of the Medicare Reform Act of 2003,” Speaker, Korean Drug Research Association, Seoul National University, Republic of Korea, February 2004

© 2007 Roylance, Abrams, Berdo & Goodman, L.L.P. All rights reserved.